CA
NZ
UK
AU
IND
US
ORIX Corporation filed a Form 6-K with the U.S. Securities and Exchange Commission on November 9, 2026, reporting consolidated financial results for the six months ended September 30, 2026, an interim dividend declaration, and a notice regarding equity method investment income recognition.
Kim McIntosh, GVP, Controller and CAO of Sally Beauty Holdings, Inc., filed a Form 4 on November 9, 2026, disclosing the acquisition of five tranches of restricted stock units on November 4, 2026, covering both newly granted RSUs and earned performance stock units.
Meitav Investment House Ltd filed Amendment No. 5 to Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of Ordinary Shares of G Willi Food International Ltd as of November 5, 2026.
Somnigroup International Inc. filed a Form 8-K on November 9, 2026, disclosing its financial results for the quarter ended September 30, 2026, a revision to its 2026 financial guidance, and a quarterly cash dividend declaration by its Board of Directors.
Somnigroup International Inc. filed a dividend announcement on November 9, 2026, disclosing that its Board of Directors declared a fourth quarter cash dividend of $0.17 per share on its common stock.
Hyperscale Data, Inc. (NYSE American:GPUS), an artificial intelligence data center company, announced on November 9, 2026, that it intends to commence an exchange offer to purchase up to 192,307,692 shares of its Class A Common Stock in exchange for units consisting of cash and …
SBA Communications Corporation filed an 8-K on November 9, 2026, disclosing that it entered into a $2.0 billion senior unsecured Term Loan Credit Agreement dated November 6, 2026, and drew $1.165 billion in initial term loans to repay its Secured Tower Revenue Securities, Series …
Sable Offshore Corp. filed a Form 8-K on November 9, 2026, disclosing the release of its financial results for the period ended September 30, 2026, and the posting of new investor presentation materials.
Abeona Therapeutics Inc. filed a Form 8-K on November 9, 2026, disclosing that on November 6, 2026, the company entered into an Asset Purchase Agreement with Ellodi Pharmaceuticals, L.P. to acquire substantially all assets related to the clinical-stage EoE candidate APT-1011, and separately closed …
Sable Offshore Corp. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 9, 2026, reporting a nine-month net loss of $530,564 thousand and first-time oil and gas revenues following the restart of …
Please wait processing your request...